| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks
2 companies
Kingsley Alfred D is a Director at Lineage Cell Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 7 sells.
Estimated insider holdings value: $9.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | IMDX Insight Molecular Diagnostics Inc. | Director | Buy | 30,000 | $0.21 | $6,447.00 | +6.8% | -23.9% | -38.0% | |
| Dec 22, 2022 | IMDX Insight Molecular Diagnostics Inc. | Director | Buy | 25,000 | $0.29 | $7,125.00 | +6.0% | -16.8% | -56.0% | |
| Aug 15, 2022 | IMDX Insight Molecular Diagnostics Inc. | Director | Buy | 10,000 | $0.97 | $9,700.00 | +1.2% | -57.7% | -82.8% | |
| Dec 23, 2020 | IMDX Insight Molecular Diagnostics Inc. | - | Sale+OE | 900 | $2.55 | $2,295.00 | -0.3% | - | - | |
| Dec 22, 2020 | IMDX Insight Molecular Diagnostics Inc. | - | Sale+OE | 42,800 | $0.31 | $13,075.92 | -4.3% | - | - | |
| Jul 31, 2017 | LCTX Lineage Cell Therapeutics, Inc. | See Remarks | Sell | 150,000 | $2.80 | $420,000.00 | -2.5% | - | - | |
| Jan 20, 2016 | LCTX Lineage Cell Therapeutics, Inc. | See Remarks | Sell | 300,000 | $2.35 | $705,000.00 | -5.1% | - | - | |
| Nov 6, 2015 | LCTX Lineage Cell Therapeutics, Inc. | See Remarks | Sell | 100,000 | $3.83 | $383,000.00 | -1.7% | - | - |